Report of consensus panel 1 from the 11

Humans Rituximab / therapeutic use Waldenstrom Macroglobulinemia / drug therapy Immunoglobulin Light-chain Amyloidosis Consensus Prospective Studies Bendamustine Hydrochloride / therapeutic use
BTK-inhibitors CXCR4 Chemoimmunotherapy MYD88 Treatment-naïve Waldenstrom's Macroglobulinemia

Journal

Seminars in hematology
ISSN: 1532-8686
Titre abrégé: Semin Hematol
Pays: United States
ID NLM: 0404514

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 09 03 2023
accepted: 09 03 2023
medline: 19 6 2023
pubmed: 26 4 2023
entrez: 26 4 2023
Statut: ppublish

Résumé

Consensus Panel 1 (CP1) of the 11

Identifiants

DOI: 10.1053/j.seminhematol.2023.03.005 PMID: 37099027
pubmed: 37099027
pii: S0037-1963(23)00026-4
doi: 10.1053/j.seminhematol.2023.03.005
pii:
doi:

Substances chimiques

Rituximab 4F4X42SYQ6
Bendamustine Hydrochloride 981Y8SX18M

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-79

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Christian Buske (C)

University Hospital Ulm, Institute of Experimental Cancer Research, Ulm, Germany. Electronic address: christian.buske@uni-ulm.de.

Jorge J Castillo (JJ)

Dana Farber Cancer Institute, Harvard Medical School, Boston MA.

Jithma Prasad Abeykoon (JP)

Mayo Clinic, Rochester MN.

Ranjana Advani (R)

Stanford University Medical Center, Stanford CA.

Suzanne O Arulogun (SO)

University College London Hospitals, London UK.

Andrew R Branagan (AR)

Massachusetts General Hospital, Boston MA.

Xinxin Cao (X)

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Shirley D'Sa (S)

University College London Hospitals, London UK.

Jian Hou (J)

Renji Hospital, Shanghai China.

Prashant Kapoor (P)

Mayo Clinic, Rochester MN.

Efstathios Kastritis (E)

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.

Marie J Kersten (MJ)

Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam/LYMMCARE, Amsterdam, Netherlands.

Veronique LeBlond (V)

Groupe Hospitalier Pitié-Salpêtrière, Sorbonne University, Paris France.

Merav Leiba (M)

Faculty of Health Science, Ben- Gurion University of the Negev, Israel Assuta Ashdod University Hospital; Faculty of Health Science, Ben-Gurion University of the Negev, Negev, Israel Memorial Sloan Kettering Cancer Center, New York, NY.

Jeffrey V Matous (JV)

Colorado Blood Cancer Institute, Sarah Cannon Research Institute, Denver, CO.

Jonas Paludo (J)

Mayo Clinic, Rochester MN.

Lugui Qiu (L)

National Clinical Medical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.

Constantine S Tam (CS)

Alfred Health, Monash University, Melbourne, Australia.

Alessandra Tedeschi (A)

A.O. Ospedale Niguarda Ca' Granda, Milan, Italy.

Sheeba K Thomas (SK)

University of Texas, MD Anderson Cancer Center, Houston, TX.

Ibrahim Tohidi-Esfahani (I)

Concord Repatriation General Hospital, University of Sydney, Sydney, Australia.

Marzia Varettoni (M)

Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Josephine M Vos (JM)

Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam/LYMMCARE, Amsterdam, Netherlands.

Ramon Garcia-Sanz (R)

Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, CIBERONC and Center for Cancer Research-IBMCC (University of Salamanca-CSIC), Salamanca, Spain.

Jesus San-Miguel (J)

Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red Cáncer, Pamplona, Spain.

Meletios A Dimopoulos (MA)

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.

Steven P Treon (SP)

Dana Farber Cancer Institute, Harvard Medical School, Boston MA.

Judith Trotman (J)

Concord Repatriation General Hospital, University of Sydney, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Report of consensus panel 1 from the 11
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps monoclonaux › Anticorps monoclonaux d'origine murine › Rituximab › Report of consensus panel 1 from the 11
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Paraprotéinémies › Macroglobulinémie de Waldenström › Report of consensus panel 1 from the 11
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Paraprotéinémies › Amylose à chaine légère d'immunoglobuline › Report of consensus panel 1 from the 11
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › Report of consensus panel 1 from the 11
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Report of consensus panel 1 from the 11
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Benzimidazoles › Chlorhydrate de bendamustine › Report of consensus panel 1 from the 11